Invention Grant
- Patent Title: Crystalline polymorphic forms of an antidiabetic compound
-
Application No.: US14669303Application Date: 2015-03-26
-
Publication No.: US09272999B2Publication Date: 2016-03-01
- Inventor: John Y. L. Chung , Yanfeng Zhang , Aaron S. Cote , Jeremy Scott , Yekaterina Vaynshteyn
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Anna L. Cocuzzo; Catherine D. Fitch
- Main IPC: C07D209/18
- IPC: C07D209/18
Abstract:
The present invention relates to polymorphic forms of a compound of formula A: This compound is useful as a glucagon receptor antagonist and serves as a pharmaceutically active ingredient for the treatment of type 2 diabetes and related conditions, such as hyperglycemia, obesity, dyslipidemia, and the metabolic syndrome. Hydrates, hemihydrates, anhydrates and similar polymorphic forms are included.
Public/Granted literature
- US20150197490A1 CRYSTALLINE POLYMORPHIC FORMS OF AN ANTIDIABETIC COMPOUND Public/Granted day:2015-07-16
Information query
